Illumina slashes costs by $100 million after China bans its sequencers. The company lowers its 2025 EPS outlook and aims for ...

Brown Advisors, an investment management company, released its “Brown Advisors Global Leaders Strategy” fourth quarter 2024 ...

and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. Receive News & Ratings for Illumina Daily - Enter your email address below to ...

Mammalian genomes are organized by multi-level folding, yet how this organization contributes to cell type-specific transcription remain unclear. We uncovered that the nuclear protein SATB1 ...

Private Advisor Group LLC lifted its position in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 2.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange ...

Consumables, such as sequencing kits for specific genomes, are the main revenue driver with over 70% revenue contribution. We expect strong consumables growth as customers transition to Illumina ...

Illumina, Inc. (NASDAQ ... X single-flow-cell system alongside a cutting-edge software upgrade and new kits.

Effortlessly extract high-quality cfDNA with automated, next-generation sequencing-ready solutions tailored for neonatal ...

The top-up is expected to help Singapore compete in areas including AI and quantum computing. Read more at straitstimes.com.